Expression of CD_(44)V_6 in invasive breast carcinoma and its relationship with prognostic significance
Bi Zhang
Abstract
Bi Zhang
Abstract
Objective To evaluate the relationship between CD_ 44V_6 and the prognosis in invasive breast carcinoma.Methods Comparison was made between 31 paitents with axillary node negative carcinoma and 25 patients with axillary node positive carcinoma for a minimum follow-up of 8 years.The level of CD_ 44V_6 (56 cases) expression was observed and compared with clinical and pathologic factors affecting prognosis and survival.Results Positive rate of CD_ 44V_6 expression was 80.4%.CD_ 44V_6 expression increased in node positive and high histologic grade patients.Conclusion Up regulation of CD_ 44V_6 expression correlates with malignancy of breast cancer.CD_ 44V_6 expression may serve as an important indicator of prognosis and guidance for clinical treatment.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To evaluate the relationship between CD_ 44V_6 and the prognosis in invasive breast carcinoma.Methods Comparison was made between 31 paitents with axillary node negative carcinoma and 25 patients with axillary node positive carcinoma for a minimum follow-up of 8 years.The level of CD_ 44V_6 (56 cases) expression was observed and compared with clinical and pathologic factors affecting prognosis and survival.Results Positive rate of CD_ 44V_6 expression was 80.4%.CD_ 44V_6 expression increased in node positive and high histologic grade patients.Conclusion Up regulation of CD_ 44V_6 expression correlates with malignancy of breast cancer.CD_ 44V_6 expression may serve as an important indicator of prognosis and guidance for clinical treatment.
Key concepts: Medicine, Breast carcinoma, Breast cancer, Malignancy, Oncology, Carcinoma, Clinical significance, Internal medicine